ALIKO Scientific Announces Settlement of a Dispute Involving Its US Subsidiary, Which Will Receive USD 2 Million

PARIS–(BUSINESS WIRE)–Regulatory News: ALIKO Scientific (Ikonisys SA – Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, announces that its wholly-owned US subsidiary has reached a settlement resolving an existing dispute, pursuant to which it will receive a payment of USD 2 million. The related proceedings have been dismissed. About ALIKO SCIENTIFIC Headquartered in Paris, ALIKO SCIENTIFIC is the parent company of an internation

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.